because Tamiflu is Relenza's block buster competitor, and if it don't work there is only one left that does.... and the nearest close but not commercially available alternative is LANI which BTA has a stake in.
I suspect most of the insto buying is on the back of Tamiflu resistance fears... and where it leads..
